Skip to main content

Biography

Dr Christopher Stanley is Leader of the Microvascular Research Unit at HRI and University of Sydney Research Affiliate.

Born in the United Kingdom, Dr Stanley completed his undergraduate Bachelor of Science degree in Pharmacology and Physiology at Leeds Metropolitan University with a first class honours and was awarded ‘Best Dissertation and Best Lab Project’ for his work in cannabinoid pharmacology. This was followed by doctoral studies in the same subject at the University of Nottingham, obtaining his PhD in 2013. Following this, he focused his interest on the project ‘Human microvascular structure and function’ at the University of Oxford with the laboratory of Professors Kim Dora and Chris Garland.

After moving to Australia in 2014, Dr Stanley joined Victor Chang Cardiac Research Institute and worked in the laboratory of Prof Roland Stocker on the project ‘Regulation of vascular tone through ID01 mediated vasorelaxation’. In his appointment, Dr Stanley was awarded a Society for Free Radical Research Young Investigator Award, a Sydney Cardiovascular Symposium Rising Star Award and the UNSW St Vincent’s Clinical School Publication of the Year Award.

In August 2020, Chris joined HRI to start and lead the Microvascular Research Unit.

Current appointments

Group Lead – Heart Research Institute

Research Affiliate – The University of Sydney

Prizes and awards

2020 UNSW St Vincent’s Clinical School Publication of the Year Award

2019 Sydney Cardiovascular Symposium Rising Star Award

2017 Victor Chang Cardiac Research Institute: Paul Korner Seminar Series, Faculty Award

2015 Society for Free Radical Research Young Investigator Award

2011 British Heart Foundation Travel Award

2011 British Pharmacological Society Competitive Travel Award

2010 British Pharmacological Society Competitive Travel Award

2009 Best Lab-based project: Leeds Metropolitan University

2009 Best Dissertation: Leeds Metropolitan University

Selected publications

Stanley CP et al. Singlet Molecular Oxygen Regulates Vascular Tone and Blood Pressure in Inflammation. Nature 2019; 566 p548.

Cheng D et al. Inhibition of myeloperoxidase attenuates endothelial dysfunction in mouse models of vascular inflammation and atherosclerosis. Arterioscl Thromb Vasc Biol 2019: 39: p1448.

Herring N et al. Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction. Eur Heart J 2019; 40 p1920.

Zardoya-Laguardia P et al. Endothelial indoleamine 2,3-dioxygenase-1 regulates the placental vascular tone and is deficient in intrauterine growth restriction and pre-eclampsia. Sci Rep 2018; 8 p5488.

HRI breakthrough drug for coronavirus

Read full article